← Back to all earnings calls

Insight Molecular Diagnostics Inc. Q2 FY2023 Earnings Call

Insight Molecular Diagnostics Inc. (IMDX)

Earnings Call FY2023 Q2 Call date: 2023-08-10 Concluded

Share

Quarter scorecard

Revenue

$463,000

-77.6% YoY

Diluted EPS

$-1.07

Gross margin

58.7%

+73.9 pp YoY

Net income

-$8.33M

Documents & deck